Capital Wealth Capital Wealth Client Login
Home Intelligence Portfolios Annuities
Planning
Planning Overview Pension Maximization 403(b) for Teachers 401(k) Planning Cash Balance & DB Plans Police / Fire & County Safety Federal, Postal & Nurses Social Security Timing Sequence of Returns Modern Portfolio Theory Life Insurance Long-Term Care & ADLs Medicare & Retiree Health Estate Planning Tax-Efficient Withdrawal 2026 Tax Guide
Advanced Planning
Executive Compensation Oil & Gas Sector Canadian Cross-Border Calculators Services About Client Login
MON CLOSE · JUN 8, 2026  |  DJIA 50,786.01 ▼ 0.16%  ·  S&P 500 ▲ 0.3%  ·  NASDAQ 25,929.66 ▲ 0.9%  ·  STOXX 600 621.73 ▼ 0.1%  ·  10Y TREAS 4.550%  ·  WTI $91.30 ▲ $0.76  ·  GOLD $4,335.90 ▼ $1.20  ·  EURO $1.1535  ·  YEN 160.18  |  CAPITAL WEALTH MID-WEEK DAILY  | 
Capital Wealth
MID-WEEK DAILY  ·  Tuesday, June 9, 2026  ·  Covering Monday, June 8  ·  The AI Reset Issue  ·  Vol. III  ·  No. 129
Mid-Week · Lead Story · The AI Reset

In One Day, Apple Rebooted Siri And OpenAI Filed To Go Public. The AI Story Just Reset — And Tech Carried The Market Again.

A developer-conference stage as the AI narrative resets — Apple's Siri and OpenAI's IPO in one day.
It was a split tape with a clear winner. The Nasdaq rose 0.9% to 25,929.66 and the S&P 500 added 0.3%, while the Dow slipped 80.77 points (−0.16%) to 50,786.01 — the now-familiar pattern where Big Tech does the lifting. Underneath the numbers, two stories landed on the same day that together reset the AI narrative: at Tim Cook's final Worldwide Developers Conference as CEO, Apple unveiled an AI version of Siri built on Google's Gemini; and OpenAI, the company that started this whole era, filed paperwork to go public.

Step back and the theme is consolidation. After Friday's chip scare, the market spent Monday voting for the names with real products and real cash flow. Apple (AAPL) finally has an AI story — and tellingly, it leaned on Alphabet (GOOGL) to get there rather than going it alone. OpenAI's IPO filing forces the public market to put a price on a pure-play AI company for the first time, which will move sentiment across every AI-linked name we hold. And Nvidia (NVDA) kept widening its moat, this time across Asia. None of this is hype for its own sake; it's the AI trade maturing into a smaller circle of winners.

We made one addition today — Corning (GLW), straight off Amazon's multibillion-dollar fiber deal — and reinforced the names this news strengthens: Apple, Nvidia, the IPO banks, defense, energy and the GLP-1 leaders. The reasoning is below; the cascaded positions are on the Portfolios page.

Monday's Tape · Technology

A Smarter Siri, And A Farewell: Apple Bets Its AI On Google's Engine.

A hand holding a smartphone showing a glowing blue voice-assistant orb.

Apple (AAPL) used its big developer showcase to introduce an AI version of Siri — one built with technology developed alongside Alphabet's Google (GOOGL) — that can finally draw on your own data to answer more complicated questions and complete tasks, instead of punting them to a web search. The event doubled as a send-off: it was Tim Cook's 15th and final WWDC as chief executive.

For a company that has trailed on consumer AI, leaning on Google's models is pragmatic — and it deepens an already lucrative relationship between the two. We had Apple on watch into this event rather than chasing it; with a credible AI story now in hand, we're comfortable reinforcing the position. The bigger tell is that even the biggest names are partnering up, not going it alone.

Business & Finance · The IPO Pipeline

OpenAI Files To Go Public — The First Real Gut-Check On The AI Trade.

A minimalist tech-startup lobby with a glowing neural-network sculpture.

OpenAI, the maker of ChatGPT, said it filed paperwork for an initial public offering. Until now the AI boom has been driven mostly by private money and by the public Big Tech names funding it. An OpenAI listing forces ordinary investors to put a real price on a pure AI company — a strong debut would validate the whole trade; a wobbly one would raise hard questions about how much enthusiasm is already in prices.

You don't need to own OpenAI to feel this. It is one more marquee name in a fee pipeline — SpaceX, then OpenAI — that keeps the investment banks busy into 2027. We reinforced Goldman Sachs (GS) and Morgan Stanley (MS), the two shops running the fullest IPO calendar since 2021. How OpenAI eventually trades will set the tone for every AI-linked name we hold.

Business News · AI Infrastructure

Nvidia Plants A Flag In Asia — And Widens The Moat Again.

Macro close-up of an advanced GPU chip with gold circuitry under blue light.

Nvidia (NVDA) said it will collaborate with South Korea's biggest tech companies — memory maker SK Hynix, SK Telecom and internet group Naver — to build AI infrastructure across the region, with an eye toward robotics and other industrial uses. CEO Jensen Huang also floated a tie-up with Hyundai, pairing the carmaker's manufacturing with Nvidia's AI.

The through-line: the AI build-out is going global, and Nvidia keeps positioning itself as the toll booth every project passes through. More partners means more chip demand and more of the surrounding ecosystem locked in. We reinforced Nvidia as the AI bellwether the trade keeps consolidating around.

Business News · The Picks-And-Shovels Trade

Amazon Bought A Mountain Of Glass. We Bought The Company That Makes It.

Aerial view of a sprawling data-center campus at dusk surrounded by power lines.

Amazon.com (AMZN) entered a multibillion-dollar agreement with Corning (GLW) for the optical fiber, cable and connectivity that knit its fast-growing data centers together. As AI workloads explode, the unglamorous plumbing — the cables that move data between servers — becomes a strategic asset with some of the steadiest, longest-dated contracts in the whole story.

This is the kind of name we like in an AI-infrastructure sleeve: less hyped than the chipmakers, with a real, contracted backlog now attached. We added Corning (GLW) as a starter ~1% position in the tactical tiers, and reinforced Amazon (AMZN), which keeps signaling it will spend whatever it takes to lead in cloud and AI.

The Long Read · Markets & Macro

$159 Billion In AI Bonds: Genius, Or A Bubble Inflating? Both Sides Have A Real Case.

Overhead view of an analyst's desk with monitors showing abstract blue charts.

Global bond issuance by the big AI-tech companies is on track for a record — roughly $159 billion in 2026. Spending on data centers and AI infrastructure by just four giants — Microsoft (MSFT), Alphabet (GOOGL), Amazon (AMZN) and Meta (META) — is enormous, and they've increasingly tapped the bond market, now even issuing in Canadian dollars, yen and euros, to pay for it.

Here's the debate in one line. Critics hear echoes of past credit booms that ended badly. The key difference this time: the borrowers are wildly profitable, and the extra yield investors demand to hold their bonds sits near multidecade lows — the market isn't treating this like a house of cards. But "overbuild risk" hasn't gone away, which is exactly why we stay invested in the build-out through the profitable hyperscalers and their suppliers, with position sizes kept sensible.

World News · Defense & Energy

Iran's Missiles Signal A Wider Goal — And Keep A Bid Under Oil.

A mobile air-defense launcher silhouetted against a dusk desert sky.

Iran's series of ballistic-missile salvos aimed at Israel are meant to show that, despite an intense air campaign against it, Tehran retains real strike capability — and the will to use it. Iran said it had paused its attacks but warned they could resume and widen. For markets the read-through is familiar: heightened Middle East tension keeps a floor under oil, which firmed to $91.30, and supports defense names and gold as hedges.

Our defense exposure — Lockheed Martin (LMT), RTX (RTX) and Northrop Grumman (NOC) — is built for exactly this backdrop, and the energy overweight (ExxonMobil (XOM), Chevron (CVX)) doesn't move on a single ceasefire headline. We reinforced all of them, and the gold sleeve (IAU) stays as the hedge for what nobody can price.

Opinion · Indo-Pacific

Taiwan's Arms Backlog: An Op-Ed Argues Delay Is Emboldening Beijing.

A mountainous island coastline with dramatic clouds.

Defense analyst Seth G. Jones argues the U.S. is undermining its own deterrence by slow-walking a $14 billion arms package to Taiwan — on top of a roughly $30 billion backlog of already-approved weapons still waiting to be delivered — even as China rapidly arms. It's a chronic tailwind story for defense, and a reminder of how much the world's most advanced chips depend on one nervous island, home to Taiwan Semiconductor (TSM).

We keep Taiwan Semiconductor (TSM) on the watch list rather than over-sizing it: the supply-chain chokepoint cuts both ways, and it underpins the re-shoring names in our tech and industrial sleeves. Our Taiwan crisis scenario →

Page One · China & Emerging Markets

The World's Most Unlikely Boom: Inside North Korea's Pizza-And-QR-Code Economy.

A brightly lit modern pizza restaurant interior in an Asian city.

It's a story that makes you do a double-take. North Korea's economy is flourishing in ways not seen in years — aided by arms sales and troop deployments to Russia, supplies and financing from China, and a knack for flouting sanctions. Visitors describe a Pyongyang of brick-oven pizza, QR-code payments, electric cars and a construction boom that built 10,000 new homes in a single year.

The investable point isn't North Korea — it's the picture of a multipolar world where sanctions leak and rivals backstop their partners. It's a vivid case for the de-globalization theme we keep flagging, and why we favor defense, domestic energy and supply-chain resilience over a frictionless-trade assumption.

Business News · Healthcare

The Weight-Loss Pill Era: Novo's Wegovy Tablet Tops Three Million Scripts.

A modern pharmacy counter with neatly arranged unlabeled white pill bottles.

Novo Nordisk (NVO) said prescriptions for its Wegovy weight-loss pill have surpassed three million — a big number for an oral version of a treatment that until recently mostly meant injections. A pill is far easier to start and stick with, which is how a good drug becomes a blockbuster. The flip side showed elsewhere in the race: Zealand Pharma fell after nearly a fifth of patients in a late-stage obesity-shot study dropped out over gastrointestinal side effects.

The GLP-1 wave remains one of the strongest secular growth stories in healthcare. We get our exposure through the two leaders — Novo Nordisk (NVO) and Eli Lilly (LLY) — both reinforced, and we watch the also-rans for stumbles.